Ignite Creation Date:
2025-12-24 @ 11:56 PM
Ignite Modification Date:
2026-05-21 @ 10:00 PM
Study NCT ID:
NCT05670951
Status:
RECRUITING
Last Update Posted:
2025-05-28
First Post:
2023-01-02
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Efficacy and Safety of ELGN-2112 on Intestinal Malabsorption in Preterm Infants
Sponsor:
Elgan Pharma Ltd.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
FIT-PIV
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None